While there is still an extensive debate on the initiating steps, experts agree on immune-mediated melanocyte destruction, with melanocyte-specific CD8+ T cells being able to kill melanocytes (2–4) and anti-melanocyte antibodies found in the sera of patients with vitiligo (5). The gene discussed is CD8A; the disease is vitiligo.